-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0367_11-08-2010.pdf
January 01, 2010 - populations, interventions, comparators, and
outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0368_11-08-2010.pdf
January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
September 01, 2011 - In adverse event
analysis, page 45, why weren't open label run-in phase data in the
withdrawal studies … This was a 3-
phase study (Period A) was a 4-month, open-label phase that
determined response to abatacept … The
second phase (Period B) was a 6-month, randomized, double-blind,
parallel-dosing, placebo-controlled … During the double-blind phase
(Period B), serious adverse events occurred in two patients in the
placebo … E.g., the etanercept study
(Lovell, et al.) used an active run-in phase before randomization.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0311_06-17-2008.pdf
January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in
the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0587-131115.pdf
March 06, 2013 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0075_03-10-2009.pdf
January 01, 2009 - populations, interventions, comparators, and
outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0710-140625.pdf
January 08, 2014 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0313_02-09-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0430_04-22-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
February 01, 2017 - Longer schedules, such as 30 Gy in 10 fractions in the
phase 3 trial by Patchell, continue to be most … A randomized, dose-response,
multicenter phase II study of radium-223 chloride for the palliation
of … Two-year survival follow-up of
the randomized, double-blind, placebo-controlled phase II study of
radium … Phase 2 study of a high dose
of 186Re-HEDP for bone pain palliation in patients with widespread
skeletal … RTOG 0631 Protocol
Information-Phase II/III Study of Image-Guided Radiosurgery/SBRT
for Localized Spine
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/labor-nitrous-oxide_research-protocol.pdf
August 24, 2011 - Additional discussions with the TEP following the public comment phase were also critical in
shaping … The majority of comments received during the public comment phase were judgments regarding
the effectiveness … Analytic Framework
Several comments were received during the public comment phase and TEP discussions … criteria developed based on our understanding of the literature
developed during the topic refinement phase … Weekly during the review
phase of the study, the Project Coordinator will report the number of abstracts
-
effectivehealthcare-admin.ahrq.gov/get-involved/draft-comments
February 01, 2021 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - or without radiotherapy, in locally
advanced prostate cancer (SPCG-7/SFUO-3): an
open randomised phase … A
prospective phase III randomized trial of
hypofractionation versus conventional fractionation
in … Phase III
trial of long-term adjuvant androgen deprivation after
neoadjuvant hormonal cytoreduction … I, Clinical Trial, Phase II,
Clinical Trial, Phase III, Clinical Trial, Phase IV
NOT
metasta*[ti] … I, Clinical Trial, Phase
II, Clinical Trial, Phase III, Clinical Trial, Phase IV
SEARCH STRATEGY
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - or without radiotherapy, in locally
advanced prostate cancer (SPCG-7/SFUO-3): an
open randomised phase … A
prospective phase III randomized trial of
hypofractionation versus conventional fractionation
in … Phase III
trial of long-term adjuvant androgen deprivation after
neoadjuvant hormonal cytoreduction … I, Clinical Trial, Phase II,
Clinical Trial, Phase III, Clinical Trial, Phase IV
NOT
metasta*[ti] … I, Clinical Trial, Phase
II, Clinical Trial, Phase III, Clinical Trial, Phase IV
SEARCH STRATEGY
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … Results
The table below lists the 15 topics for which (1) preliminary phase III data for drugs or phase … In September 2011, the company announced plans for its phase III
trial after releasing final 48-week … results from its phase II trial. … Intarcia presents positive ITCA 650 phase 2
study results for type 2 diabetes at EASD.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_644-03-07-2013.pdf
January 01, 2013 - populations, interventions, comparators, and outcomes, will be further developed in the refinement
phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0108_05-24-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0122_06-29-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0004_03-11-2008.pdf
January 01, 2008 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0272_03-06-2008.pdf
January 01, 2008 - populations, interventions, comparators, and outcomes, will
be further developed in the refinement phase